N/A
Completed N=370
GEnetic Counseling Through Virtual Visits in Parkinson's Disease
Source: ClinicalTrials.gov NCT04527146 ↗Enrolled (actual)
370
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Genetics Knowledge — 16; 17; 17; 16 score on a scale
Summary
The research study is being conducted to compare methods of virtual genetic counseling for people with Parkinson's disease.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Genetics Knowledge |
16; 17; 17; 16 | — |
| PRIMARY Genetic Counseling Satisfaction (Post-Test) |
24; 25; 25; 26 | — |
| PRIMARY Test-Related Distress |
0; 0; 0; 0 | — |
| SECONDARY Genetic Counseling Satisfaction (Pre-Test) |
22; 23; 24; 25 | — |
| SECONDARY Depression |
3; 3; 3; 3 | — |
| SECONDARY State-Trait Anxiety Index-State Score |
35; 36; 35; 36 | — |
| SECONDARY State-Trait Anxiety Index -State Score |
35; 36; 34.5; 36 | — |
| SECONDARY State-Trait Anxiety Index -Trait Score |
34; 34; 35; 35 | — |
| SECONDARY Quality of Life in Parkinson's Disease |
20.99; 15.31; 17.79; 19.22 | — |
| SECONDARY Test-Related Distress |
0; 0; 0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Provision of signed and dated informed consent form
- Stated willingness to have clinical confirmation genetic testing, and comply with all study procedures and availability for the duration of the study
- Male or female, over the age of 21.
- English Speaking
Exclusion Criteria
- Prior genetic counseling and/or clinical testing specifically for Parkinson's disease
- Montreal Cognitive Assessment (MoCA) < 21, or a prior diagnosis of dementia during the screening phase
Data sourced from ClinicalTrials.gov (NCT04527146). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.